1. Home
  2. OOMA vs MDXG Comparison

OOMA vs MDXG Comparison

Compare OOMA & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ooma Inc.

OOMA

Ooma Inc.

HOLD

Current Price

$20.02

Market Cap

517.6M

Sector

Technology

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$4.20

Market Cap

625.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OOMA
MDXG
Founded
2003
2006
Country
United States
United States
Employees
N/A
808
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
517.6M
625.6M
IPO Year
2015
2007

Fundamental Metrics

Financial Performance
Metric
OOMA
MDXG
Price
$20.02
$4.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$18.77
$9.00
AVG Volume (30 Days)
314.1K
1.2M
Earning Date
05-27-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
188.46
14.29
EPS
0.09
N/A
Revenue
$114,490,000.00
$418,630,000.00
Revenue This Year
$20.35
N/A
Revenue Next Year
$4.17
$13.02
P/E Ratio
$215.11
N/A
Revenue Growth
9.53
19.99
52 Week Low
$9.79
$3.03
52 Week High
$21.96
$7.99

Technical Indicators

Market Signals
Indicator
OOMA
MDXG
Relative Strength Index (RSI) 55.63 56.99
Support Level $10.78 $3.50
Resistance Level $21.57 $4.45
Average True Range (ATR) 0.88 0.16
MACD -0.10 -0.02
Stochastic Oscillator 52.24 40.96

Price Performance

Historical Comparison
OOMA
MDXG

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that delivers voice and collaboration features, including messaging, intelligent virtual attendants, and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: